The rising popularity in GLP-1 agonists for diabetes has sparked a debate about formats: skin-applied devices versus capsules. Usually , GLP-1 therapies were only available in oral form, but the https://shaunauoxu423573.aioblogs.com/93669513/glp-1-transdermal-delivery-systems-vs-pills-which-suitable-for-individuals